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Hepatocellular carcinoma (HCC) is the fifth most frequent human cancer worldwide, with the 
highest frequency in countries where hepatitis B and C are endemic and food is contaminated by 
Aflatoxin 81 . HCC incidence is on the rise in Europe and United States, due to the increased 
incidence of hepatitis C virus infection, cirrhosis related to type 11 diabetes, and non-alcoholic 
steatohepatitis. For these reasons there is a need for more therapies with pharmacological agents 
to help the improvement of the prognosis of patients with HCC. In this study ten methyl 3-amino-6-
(arylethynyl)thieno[3,2-b]pyridine-2-carboxylates [1] were investigated for their anti-proliferative 
activity in the HEPG2 hepatocellular carcinoma cell line using the sulforhodamine assay. In order 
to investigate the liver cytotoxicity of the compounds, the same assay was applied using a primary 
liver cells culture prepared from fresh pig hepatocytes (liver biopsy). This assay is very important 
as mammalian hepatocytes still represent an obligatory step in the evaluation of toxic compounds 
that lead to the production of various metabolites, which are the ultimate cause of toxicity. 
0 
OMe 
1 R1=R2=R3=H 
2 R1=NH2. R2=R3=H 
3 R1=R3=H, R2=NH2 
4 R1=R2=H, R3=NH2 
5 R1=0Me, R2=R3=H 
6 R1=R3=H, R2=0Me 
7 R1=R2=H, R3=0Me 
8 R1=F, R2=R3=H 
9 R1=R2=H, R3=F 
10 R1=R2=H, R3=N(Me)2 
Among the compounds studied, compound 3 with an amino group in the meta position showed the 
best anti-proliferative activity against HEPG2 cell? .{ICso = 1.2 IJM). Curiously, compounds 4 and 2, 
with the amino group on the para or ortho pos1t1on . sh<?wed moderated {IC50 = 26 IJM) and no 
activity (IC50 > 125 JJM), respect1v~ly. lt sh~uld be h1gh~1ghted ~hat the three compounds did not 
show cytotoxicity (IC50 > 125 JJM) m. the pnm~rx hepat1c cell l1 ne used. This comparison shows 
that, not only the presence of the ~n;mo gro~p 1.s Important, but also its relative position. This work 
shows that these thieno[3,2bJP.Y:Jdl.ne der~vat1v~s are promising new pharmacological agents 
against HCC, not preseniing cytotox1c1ty m the pnmary liver cells. 
[1]- Calhelha RC, Queiroz M-JRP Tetrahedron Lett. 2010 , 51,281-283. 
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